923036-28-6

Usage

Uses

Used in Pharmaceutical Industry:
(1-Benzyl-4-Methyl-1,2,5,6-tetrahydropyridin-3-yl)carbaMic acid Methyl ester is used as a potential candidate for the development of new drugs due to its structure suggesting biological activity in the central nervous system. It may contribute to the creation of treatments for neurological disorders.
Used as a Research Tool in Neuroscience:
In the field of neuroscience, (1-Benzyl-4-Methyl-1,2,5,6-tetrahydropyridin-3-yl)carbaMic acid Methyl ester serves as a valuable research tool, aiding scientists in studying the central nervous system and the development of neurological therapies.
Used in Organic Synthesis:
Owing to its unique chemical properties, (1-Benzyl-4-Methyl-1,2,5,6-tetrahydropyridin-3-yl)carbaMic acid Methyl ester is utilized as a useful reagent in organic synthesis, potentially leading to the creation of new compounds and materials.

Upstream product

• 923036-27-5 1-benzyl-3-methoxycarbonylamino-4-methyl-pyridinium bromide 
• 923036-29-7 1-benzyl-3-methoxycarbonylamino-4-methylpyridinium chloride 

Downstream Products

• 477600-70-7 N-(3R,4R)-(1-benzyl-4-methylpiperidin-3-yl)-methylamine 
• 1354621-59-2 (3S,4S)-1-benzyl-N,4-dimethylpiperidin-3-amine 
• 1354621-59-2 trans-(1-benzyl-4-methylpiperidin-3-yl)methylamine 
• 1206875-41-3 cis-(1-Benzyl-4-methyl-piperidin-3-yl)-carbamic Acid Methyl Ester 
• 1062580-52-2 N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-N-methylamine dihydrochloride 
• 1228879-37-5 (3R,4R)-1-benzyl-N,4-dimethylpiperidine-3-amine dihydrochloride 

Relevant academic research and scientific papers

PIPERIDINE INHIBITORS OF JANUS KINASE 3

The present invention relates to a new piperidine inhibitors of Janus Kinase 3 activity, pharmaceutical compositions thereof, and methods of use there-of.

PYRROLO[2,3-D]PYRIMIDINE DERIVATIVES; THEIR INTERMEDIATES AND SYNTHESIS

This invention relates to methods and intermediates useful for the synthesis of pyrrolo [2,3-d] pyrimidine compounds. Specifically novel synthetic methods and intermediates for the synthesis of 3- {(3R, 4R)-4-methyl-(7H-pyrrolo[2,3-d] pyrimidin-4-yl)-amino}-piperidin-1-yl)-3-oxo-propionitrile and its corresponding citrate salt are disclosed.